» Articles » PMID: 38764077

Synergistic Effect of Umbilical Cord Extracellular Vesicles and RhBMP-2 to Enhance the Regeneration of a Metaphyseal Femoral Defect in Osteoporotic Rats

Overview
Publisher Biomed Central
Date 2024 May 19
PMID 38764077
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to evaluate potential synergistic effects of a single, local application of human umbilical cord MSC-derived sEVs in combination with a low dose of recombinant human rhBMP-2 to promote the regeneration of a metaphyseal femoral defect in an osteoporotic rat model.

Methods: 6 weeks after induction of osteoporosis by bilateral ventral ovariectomy and administration of a special diet, a total of 64 rats underwent a distal femoral metaphyseal osteotomy using a manual Gigli wire saw. Defects were stabilized with an adapted Y-shaped mini-locking plate and were subsequently treated with alginate only, or alginate loaded with hUC-MSC-sEVs (2 × 10), rhBMP-2 (1.5 µg), or a combination of sEVs and rhBMP-2 (n = 16 for each group). 6 weeks post-surgery, femora were evaluated by µCT, descriptive histology, and biomechanical testing.

Results: Native radiographs and µCT analysis confirmed superior bony union with callus formation after treatment with hUC-MSC-sEVs in combination with a low dose of rhBMP-2. This finding was further substantiated by histology, showing robust defect consolidation 6 weeks after treatment. Torsion testing of the explanted femora revealed increased stiffness after application of both, rhBMP-2 alone, or in combination with sEVs, whereas torque was only significantly increased after treatment with rhBMP-2 together with sEVs.

Conclusion: The present study demonstrates that the co-application of hUC-MSC-sEVs can improve the efficacy of rhBMP-2 to promote the regeneration of osteoporotic bone defects.

Citing Articles

Therapeutic Efficacy and Promise of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Aging and Age-Related Disorders.

Zhang A, Li Q, Chen Z Int J Mol Sci. 2025; 26(1.

PMID: 39796081 PMC: 11719504. DOI: 10.3390/ijms26010225.

References
1.
Bowles-Welch A, Jimenez A, Stevens H, Frey Rubio D, Kippner L, Yeago C . Mesenchymal stromal cells for bone trauma, defects, and disease: Considerations for manufacturing, clinical translation, and effective treatments. Bone Rep. 2023; 18:101656. PMC: 10323188. DOI: 10.1016/j.bonr.2023.101656. View

2.
Takov K, Yellon D, Davidson S . Confounding factors in vesicle uptake studies using fluorescent lipophilic membrane dyes. J Extracell Vesicles. 2017; 6(1):1388731. PMC: 5699187. DOI: 10.1080/20013078.2017.1388731. View

3.
Morelli A, Larregina A, Shufesky W, Sullivan M, Stolz D, Papworth G . Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004; 104(10):3257-66. DOI: 10.1182/blood-2004-03-0824. View

4.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T . Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9(7):676-82. PMC: 3855844. DOI: 10.1038/nmeth.2019. View

5.
Zeng Z, Xie H . Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review. Biomater Transl. 2023; 3(3):175-187. PMC: 9840092. DOI: 10.12336/biomatertransl.2022.03.002. View